what are the Recommendations for Antithrombotic Therapy for Prosthetic Valves
(Continued)?
For patients with a bioprosthetic TAVI who are at low risk of bleeding, anticoagulation with a VKA to achieve an INR of 2.5 may be reasonable for at least 3 months after valve implantation.